- Elite Trade Club
- Posts
- Boeing Plunges After South Korea Crash
Boeing Plunges After South Korea Crash
Good morning. It's December 30th, and today we’ll look at Boeing, Google, Ibiden, and a pharma stock that’s rising more than 100%+ in premarket trade.
📲 Want our updates via text message? Get Elite Trade Club's pre-market insights and hottest stocks straight to your cell for 100% free. Click here to sign up.
Income-Generating Assets
For years, high-performing commercial properties leased by industry leaders like Walmart, Kroger, and CVS were accessible only to major institutions.
These necessity-based assets are designed for stability, offering consistent cash flow and the potential for long-term appreciation—making them a powerful addition to a well-rounded portfolio.
With access to off-market deals and a team of experienced professionals guiding the way, this is your opportunity to invest in assets built for growth and resilience.
Take the first step toward building lasting wealth with institutional-grade investments.
Futures 📈
What to Watch
Chicago Business Barometer (PMI) (Dec): 9:45 a.m.
Pending Home Sales (Nov): 10:00 a.m.
There are no major earnings reports due today.
Airlines
Boeing Stock Hit After Deadly South Korea Crash
Boeing shares are down 4% in premarket trading today following a deadly crash involving a 737-800 operated by South Korea’s Jeju Air. The accident claimed 179 lives and is the latest in a series of setbacks for the U.S. aerospace giant.
The plane, en route from Bangkok, Thailand, to South Korea’s Muan County, crashed into a concrete barrier while attempting to land on Sunday, bursting into flames. Of the 181 passengers and crew aboard, only two survived, according to local authorities.
Shares of Jeju Air, a budget airline founded in 2005, closed nearly 9% lower at an all-time low on the Seoul stock exchange.
This incident adds to Boeing's growing list of challenges. Earlier this year, a mid-air incident involving a 737 MAX led to safety concerns and regulatory scrutiny from the Federal Aviation Administration (FAA). Additionally, a recent two-month strike by Boeing’s union machinists further strained the company’s operations and finances.
In a statement, Boeing expressed condolences to the victims' families and pledged support to Jeju Air. Boeing shares have already fallen 30% this year, reflecting mounting pressure from quality issues, regulatory hurdles, and financial strain.
Technology
Sundar Pichai Calls 2025 Critical for Google’s AI Strategy
Google CEO Sundar Pichai has emphasized the importance of 2025 as a pivotal year for the tech giant, underscoring the need to accelerate progress in artificial intelligence (AI) amidst intensifying competition and regulatory scrutiny.
According to an audio recording from a recent strategy meeting, Pichai encouraged employees to act with urgency, stating, “The stakes are high. These are disruptive moments.”
The company aims to leverage its Gemini AI model to address real-world user needs. Pichai highlighted the potential of the Gemini app to become Google’s next major consumer success, targeting over 500 million users. The CEO identified scaling Gemini as the company’s top priority for 2025, marking it as a critical step in maintaining a leadership position in AI.
Despite Google’s dominance in search and advertising, it faces mounting challenges from generative AI competitors like OpenAI, whose ChatGPT has reshaped how users access information. Additionally, regulatory pressures loom large, with global investigations into Google’s ad tech practices and accusations of monopolistic behavior in the search market.
Pichai acknowledged the growing scrutiny but stressed the importance of staying focused, stating, “It is not lost on me that we are facing scrutiny across the world. Through this moment, we have to make sure we don’t get distracted.”
Technology
Ibiden Ramps Up Substrate Production as AI Demand Surges
Ibiden Co., a key supplier for NVIDIA, is exploring faster capacity expansion to address surging demand for AI-use substrates, CEO Koji Kawashima said in an interview.
The Japanese company, which specializes in advanced semiconductor substrates, is constructing a new factory in Gifu Prefecture. The facility will begin production at 25% capacity by late 2025 and reach 50% by March 2026. Discussions are already underway to activate the remaining capacity sooner than planned.
Kawashima noted that the firm’s customers are already urging it to grow faster. Clients like NVIDIA, Intel, AMD, and TSMC heavily rely on Ibiden’s technology. Substrates are critical for AI chips, ensuring they can handle the intense heat generated by high-performance semiconductors.
Despite a challenging year with shares down 40% due to sluggish general server demand, Ibiden remains optimistic about its AI segment. The firm’s AI-related revenue currently accounts for over 15% of its ¥370 billion ($2.3 billion) sales and is poised to grow further. NVIDIA exclusively uses Ibiden substrates for its AI chips, securing the company’s position as a dominant supplier.
While Taiwanese rivals like Unimicron aim to enter the market, analysts believe Ibiden’s production expertise will keep its leadership intact. Kawashima reaffirmed a long-standing partnership with Intel and highlighted its role in advancing U.S. semiconductor ambitions despite not planning to establish U.S. manufacturing facilities.
AI
Elon Musk’s latest venture is poised to redefine a $9 trillion AI industry, and one under-the-radar company is at the center of it all.
This supplier, tied directly to Elon’s revolutionary tech, is expected to skyrocket—and with Musk’s big reveal scheduled for January 22nd, time is running out to get ahead of the news.
Tech investing expert Jeff Brown, known for calling winners like NVIDIA and Tesla, believes this opportunity could eclipse them all.
Before the market catches on, learn how this small company could lead the charge in AI's next wave.
The countdown is on. Don’t miss out.
Movers and Shakers
NLS Pharmaceutics Ltd. [NLSP] - Last Close: $1.82
NLS Pharmaceutics Ltd. (NLSP) shares have surged over 100% in premarket trading following the filing of an F-4 registration statement with the SEC, signaling progress in their proposed merger with Kadimastem Ltd.
This merger aims to create a Nasdaq-listed biotechnology company with advanced clinical-stage product candidates.
My Take: NLS Pharmaceutics has experienced a 91% decline in stock value over the past year, so it might be best to wait and watch before investing.
Polyrizon Ltd. [PLRZ] - Last Close: $1.64
Polyrizon Ltd. (PLRZ) has jumped more than 59% in premarket trading after announcing the publication of a U.S. National Patent application for its Hydrogel Nasal technology.
The patent covers Polyrizon’s Capture and Contain (C&C™) nasal blocker and Trap and Target (T&T™) drug delivery platforms.
My Take: The company is in the development stage with no current revenue, so be cautious while investing here.
Vincerx Pharma, Inc. [VINC] - Last Close: $0.19
Vincerx Pharma (VINC) shares are climbing over 48% in premarket trading following the announcement of a binding term sheet for a strategic merger with Oqory, Inc., a privately held, clinical-stage oncology company.
This merger aims to enhance Vincerx's oncology pipeline and strengthen its position in the biotech sector.
My Take: Vincerx has faced financial challenges, including a declining stock price over the past year. Hedge your bets before investing in this stock.
Real Estate
Imagine owning a stake in high-performing properties leased to household names like Walmart, CVS, and Kroger.
For years, these institutional-grade assets were out of reach for individual investors—until now.
Accredited investors can now access grocery-anchored and essential-service properties designed for stability and growth.
With necessity-based tenants driving consistent performance, these investments are built to weather economic shifts and deliver strong potential returns.
Opportunities like this don’t stay under the radar for long. Take your portfolio to the next level with assets built for lasting value.
Everything Else
Former President Jimmy Carter, known for humanitarian efforts and economic challenges, passed away.
UBS chief defended the financial sector against overregulation after Credit Suisse collapse.
Saudi Crown Prince's Vision 2030 faces hurdles with declining FDI inflows.
Barkat Frisian Agro targets expansion with an upcoming IPO in January.
India’s Adani sold its 44% stake in Adani Wilmar to focus on infrastructure and address public shareholding norms.
Spain's inflation remains above 2%, boosting the case for cautious ECB policy easing.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.